
Why don’t immunotherapies work for everyone? The answer isn’t entirely clear – but new research published in Science sheds some light (1). According to Lukas Mager, a senior postdoctoral researcher at the University of Calgary and first author of the paper, specific bacteria in the gut microbiome play a significant role in the success of immunotherapies in treating certain cancers.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Login
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine